European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments. - Wikidata - awgldk - TriplyDB

European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments.

European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments.

http://www.wikidata.org/entity/Q37988940

about

Vipera ammodytes bites treated with antivenom ViperaTAb: a case series with pharmacokinetic evaluation.Current treatment for venom-induced consumption coagulopathy resulting from snakebite The effect of a single dose of prednisolone in dogs envenomated by Vipera berus--a randomized, double-blind, placebo-controlled clinical trial Bilateral Pulmonary Embolism Following a Viper Envenomation in France: A Case Report and Review Snakebite management in Iran: Devising a protocol Antivenom for European Vipera species envenoming.Two decades of pharmacovigilance and clinical experience with highly purified rabies immunoglobulin F(ab')2 fragments.Poor efficacy of preemptive amoxicillin clavulanate for preventing secondary infection from Bothrops snakebites in the Brazilian Amazon: A randomized controlled clinical trial Hyperglycemia is a risk factor for high-grade envenomations after European viper bites (Vipera spp.) in children.A Single Dose of Viperfav(TM) May Be Inadequate for Vipera ammodytes Snake Bite: A Case Report and Pharmacokinetic Evaluation Immunological cross-reactivity and neutralisation of European viper venoms with the monospecific Vipera berus antivenom ViperaTAb Neurotoxicity of European viperids in Italy: Pavia Poison Control Centre case series 2001-2011.Exotic snake bites in the Czech Republic--Epidemiological and clinical aspects during 15-year period (1999-2013).

P2860

Q33438472-F6BF9ED9-008B-456A-8E6B-4AFF595B116E Q34394906-F8A5D474-3B30-44CD-8CDD-D4055D2C3C10 Q35147776-3B251B72-127C-4C4D-ADC0-CCC078A2092A Q36993279-8EE2DB5D-5A79-4C1E-8E18-9612E6356250 Q37723218-75783489-FF19-42EF-89DD-0188BC0B3458 Q38871647-4B862C82-FA86-4E0A-BFC3-448EF9487598 Q38997495-A9176FA4-5695-4514-B6B5-358011D0FAE8 Q39418425-144C1441-D9D5-41A3-82BC-7122885971F6 Q40306327-CE4FEADB-003D-414A-879D-FE500F790FB8 Q42331803-27977E17-FBE6-4F08-8F43-224BCF548B2E Q42847712-BF478901-4465-4628-A436-366447D101C1 Q44437909-3489AAAD-AF41-468D-AADD-8307E8C0C8C3 Q45352614-B3E3DDBE-E86D-4C0E-A193-6D400A566733

P2860

European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments.

http://www.wikidata.org/entity/Q37988940

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments.

@en

European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments.

@nl

type

label

European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments.

@en

European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments.

@nl

prefLabel

European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments.

@en

European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments.

@nl

P1433

Q37988940-92A27C00-675B-4AAB-99D7-E3CD8764BC29

P1476

Q37988940-22D3E3ED-B619-4E42-AA77-DF36D77C0FE5

P2093

Q37988940-16ECE281-DEDA-43AA-A399-8DA37B913733

Q37988940-3ED63DFF-D30B-4BE9-9602-FF609D56E76C

Q37988940-4CAB1E1F-23BA-4251-9A68-9003E84F809E

Q37988940-B51669B9-4FB0-4AD8-BEFB-9B2E9C916591

P2860

Q37988940-13301E8A-C52D-4487-901F-8804CFFF3840

Q37988940-1A841C01-56C9-48B3-9546-0EF8524D6B9F

Q37988940-21BCB08A-8249-4BAC-9370-2A32794E622E

Q37988940-2791ADA1-3BFE-4613-852E-CACDB3D0EDED

Q37988940-505C275C-ACE4-4205-8437-9BF82CB4930B

Q37988940-9222390C-A770-469A-9194-7BBA15D9846B

Q37988940-DDA05C95-CDE0-4F13-8D18-404D8BE5F503

Q37988940-E3B4CF3C-9E12-43C7-8EE2-B81136DE6078

P304

Q37988940-37DA781C-48C1-4B5A-B7D3-429F7EFF597E

P31

Q37988940-DD44723F-1194-4767-9116-7D53ECA2F1A5

P356

Q37988940-F32AE77A-78AA-4C26-A410-CA1BFA7CA2A0

P407

Q37988940-5E57C804-75EA-45CB-A967-C065F8804AD8

P433

Q37988940-D534AD9D-F276-4875-84A1-2317599B9303

P478

Q37988940-4712F256-D13C-4001-835B-FF937E5CC2D8

P577

Q37988940-260F7F5F-437A-45C5-9EAD-A3E4B82EBF89

P5875

Q37988940-65F5B9C0-7B00-4D29-BC6F-49B4B253A15B

P698

Q37988940-2B9F54C1-ECBB-48C3-A16D-C6AFF499A28D

P356

15563650.2012.660695

P1433

Clinical Toxicology

P1476

European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments.

@en

P2093

David Boels

http://www.w3.org/2001/XMLSchema#string

Jean Francois Hamel

http://www.w3.org/2001/XMLSchema#string

Marie Bretaudeau Deguigne

http://www.w3.org/2001/XMLSchema#string

Patrick Harry

http://www.w3.org/2001/XMLSchema#string

P2860

Vipera berus bites in the Region of Southwest Poland--a clinical analysis of 26 cases.

Asp Viper (Vipera aspis) envenomation: experience of the Marseille Poison Centre from 1996 to 2008.

A nationwide study of Vipera berus bites during one year-epidemiology and morbidity of 231 cases.

Antibody treatment of toxin poisoning--recent advances.

Antivenom treatment in Vipera berus envenoming--report of 30 cases.

[Emergency immunotherapy: snake and scorpion antivenoms].

Unusual neurotoxic envenomations by Vipera aspis aspis snakes in France.

[Snake bite by European vipers. A multicenter study of tolerance to Viperfav, a new intravenous antivenom]

P304

189-196

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/15563650.2012.660695

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221868898

http://www.w3.org/2001/XMLSchema#string

P698

22372786

http://www.w3.org/2001/XMLSchema#string